The value of bone marrow examination in the staging of Hodgkin's lymphoma: A review of 955 cases seen in a regional cancer centre

British Journal of Haematology

Volumn 119, Issue 2, 2002, Pages 408-411

  Howell, Sacha J ^a   Grey, Mark ^a   Chang, James ^a   Morgenstern, Godfrey R ^a   Cowan, Richard A ^a   Deakin, David P ^a   Radford, John A ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bone marrow trephine; ESR; Full blood count; Hodgkin's lymphoma; Staging

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER CENTER; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; BLOOD CELL COUNT; BLOOD SEDIMENTATION; BONE MARROW EXAMINATION; CANCER CARE FACILITIES; CHI-SQUARE DISTRIBUTION; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036440692     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03842.x     Document Type: Article

References (22)

1. Aisenberg, A.C. (1999) Problems in Hodgkin's disease management. Blood, 93, 761-779.
2. Brunning, R.D., Bloomfield, C.D., McKenna, R.W. & Peterson, L.A. (1975) Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Annals of Internal Medicine, 82, 365-366.
3. Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., Moser, E., Glatting, G., Kotzerke, J., Guhlmann, C.A., Schirrmeister, H. & Reske, S.N. (2001) 2-(Fluorine-18) fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer, 91, 889-899.
4. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research, 31, 1860-1861.
5. Dacie, J. & Lewis, S. (1995) Practical Haematology (Eighth Edition). Churchill Livingstone, Edinburgh.
6. DeVita, V.T., Mauch, P.M. & Harris, N.L. (1997) Hodgkin's Disease. In: Cancer Principles and Practise of Oncology (ed. by V.T. DeVita, S. Hellman & S.A. Rosenberg), pp 2242-2283. Lippincott-Raven, Philadelphia.
7. Doll, D.C., Ringenberg, Q.S., Anderson, S.P., Hewett, J.E. & Yarbro, J.W. (1989) Bone marrow biopsy in the initial staging of Hodg-kin's disease. Medical and Pediatric Oncology, 17, 1-5.
8. Gobbi, P.G., Comelli, M., Grignani, G.E., Pieresca, C., Bertoloni, D. & Ascari, E. (1994) Estimate of expected survival at diagnosis in Hodgkin's disease. a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD). Haematol-ogica, 79, 241-255.
9. Hasenclever, D. & Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. New England Journal of Medicine, 339, 1506-1514.
10. Hueltenschmidt, B., Sautter-Bihl, M.L., Lang, O., Maul, F.D., Fischer, J., Mergenthaler, H.G. & Bihl, H. (2001) Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer, 91, 302-310.
11. Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P. & Fillet, G. (2001) Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86, 266-273.
12. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 1630-1636.
13. Macintyre, E.A., Vaughan Hudson, B., Linch, D.C., Vaughan Hudson, G. & Jelliffe, A.M. (1987) The value of staging bone marrow trephine biopsy in Hodgkin's disease. European Journal of Haematology, 39, 66-70.
14. Mauch, P.M. (1996) Management of early stage Hodgkin's disease: The role of radiation therapy and/or chemotherapy. Annals of Oncology, 7, 79-84.
15. Moog, F., Bangerter, M., Kotzerke, J., Guhlmann, A., Frickhofen, N. & Reske, S.N. (1998) 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Journal of Clinical Oncology, 16, 603-609.
16. Munker, R., Hasenclever, D., Brosteanu, O., Hiller, E. & Diehl, V. (1995) Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. Journal of Clinical Oncology, 13, 403-409.
17. Proctor, S.J., Taylor, P., Mackie, M.J., Donnan, P., Boys, R., Lennard, A. & Prescott, R.J. (1992) A numerical prognostic index for clinical use in identification of poor-risk patients with Hodg-kin's disease at diagnosis. The Scotland and Newcastle Lym-phoma Group (SNLG) Therapy Working Party. Leukaemia and Lymphoma, 7, 17-20.
18. Rosenberg, S.A. (1971) Hodgkin's disease of the bone marrow. Cancer Research, 31, 1733-1736.
19. Specht, L. & Nissen, N.I. (1988) Prognostic factors in Hodgkin's disease stage IV. European Journal of Haematology, 41, 359-367.
20. Spector, N., Nucci, M., Oliveira De Morais, J.C., Maiolino, A., Portugal, R.D., Costa, M.A. & Pulcheri, W. (1997) Clinical factors predictive of bone marrow involvement in Hodgkin's disease. Leukaemia and Lymphoma, 26, 171-176.
21. Sutcliffe, S.B., Gospodarowicz, M.K., Bergsagel, D.E., Bush, R.S., Alison, R.E., Bean, H.A., Brown, T.C., Chua, T., Clark, R.M. & Curtis, J.E. (1985) Prognostic Groups for management of localized Hodgkin's disease. Journal of Clinical Oncology, 3, 393-401.
22. Varan, A., Cila, A. & Buyukpamukcu, M. (1999) Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease. Medical and Pediatric Oncology, 32, 267-271.